These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15200485)

  • 1. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas.
    Kumamoto H; Ooya K
    Virchows Arch; 2004 Feb; 444(2):164-70. PubMed ID: 14714184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
    Kumamoto H; Kimi K; Ooya K
    J Oral Pathol Med; 2001 Nov; 30(10):596-602. PubMed ID: 11722709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2007 Sep; 13(5):461-7. PubMed ID: 17714348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63 and p73 in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Notch signaling molecules in ameloblastomas.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2008 Apr; 37(4):228-34. PubMed ID: 18221321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas.
    Kumamoto H; Suzuki T; Ooya K
    J Oral Pathol Med; 2002 Nov; 31(10):605-11. PubMed ID: 12406306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
    Kumamoto H; Yamauchi K; Yoshida M; Ooya K
    J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2004 Mar; 33(3):185-90. PubMed ID: 15128061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.